Lipopeptides from Bacillus sp. EA-CB0959: Active metabolites responsible for in vitro and in vivo control of Ralstonia solanacearum

Vista sencilla de ítem
dc.citation.journalTitleBIOLOGICAL CONTROLspa
dc.contributor.authorVillegas Escobar, Valeska
dc.contributor.authorGonzález-Jaramillo LM
dc.contributor.authorRamirez, Maria
dc.contributor.authorMONCADA, RUTH NATALIA
dc.contributor.authorSierra Zapata, Laura
dc.contributor.authorOrduz, Sergio
dc.contributor.authorRomero, Magally
dc.contributor.departmentUniversidad EAFIT. Departamento de Cienciasspa
dc.contributor.researchgroupCiencias Biológicas y Bioprocesos (CIBIOP)spa
dc.date.accessioned2021-03-23T20:09:00Z
dc.date.available2021-03-23T20:09:00Z
dc.date.issued2018-07-31
dc.description.abstractBroadening the spectrum of action of microbial bioactive compounds is a priority nowadays. From a collection of 1493 aerobic endospore forming bacteria, 3.1% (47) inhibited Serratia marcescens and were highly active against R. solanacearum. Thirty-six of these strains were identified as part of the ‘Operational Group B. amyloliquefaciens’ denoting the potential of strains from these species to produce antibacterial substances. Specifically, the strain Bacillus sp. EA-CB0959 was selected for further trials. Three families of lipopeptides: surfactins, iturins and fengycins were found as the active compounds produced by this strain. The highest bioactivity, produced by fengycins, had a minimal inhibitory concentration of 32 µg/mL. Treating greenhouse banana plants with a mixed fraction of lipopeptides reduced by 35% the incidence of Moko disease caused by R. solanacearum. Here we provide first time evidence of in vitro antibacterial activity of purified fengycins and in vivo activity of mixed lipopetides against Moko disease in banana plants. © 2018 Elsevier Inc.eng
dc.identifierhttps://eafit.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=8143
dc.identifier.doi10.1016/j.biocontrol.2018.06.005spa
dc.identifier.issn10499644spa
dc.identifier.issn10902112spa
dc.identifier.otherWOS;000467300500001
dc.identifier.otherSCOPUS;2-s2.0-85065803210
dc.identifier.urihttp://hdl.handle.net/10784/26830
dc.language.isoengeng
dc.publisherAcademic Press Inc.
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85048926753&doi=10.1016%2fj.biocontrol.2018.06.005&partnerID=40&md5=23eb68937ebf68a6dc18363c8acb175c
dc.rightshttps://v2.sherpa.ac.uk/id/publication/issn/1049-9644
dc.sourceBIOLOGICAL CONTROL
dc.subject.keywordAntibacterial activityeng
dc.subject.keywordBiological controleng
dc.subject.keywordFengycinseng
dc.subject.keywordGram-negativeseng
dc.subject.keywordOperational Group B. amyloliquefacienseng
dc.subject.keywordRalstonia solanacearumeng
dc.titleLipopeptides from Bacillus sp. EA-CB0959: Active metabolites responsible for in vitro and in vivo control of Ralstonia solanacearumeng
dc.typearticleeng
dc.typeinfo:eu-repo/semantics/articleeng
dc.typeinfo:eu-repo/semantics/publishedVersioneng
dc.typepublishedVersioneng
dc.type.localArtículo

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
1-s2.0-S1049964418303396-main.pdf
Tamaño:
756.37 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar

Colecciones

Artículos (CIBIOP)